To better understand the benefits and risks of various screening and diagnostic approaches, the NIH is convening a Consensus Development Conference from October 29 to 31 to assess the available scientific evidence.
Read MoreThe Siemens Healthcare Diagnostics, Tarrytown, NY, DCA HbA1c test kit, already used to monitor diabetes patients’ HbA1c levels, has achieved the CE mark as an aid to diagnose diabetes and identify patients at risk for developing the disease.
Read More
As the population’s diabetes risk increases, the medical community looks at expanding glycemic testing for inpatients
Read MorePathway Genomics Corp, San Diego, has partnered with La Jolla, Calif, medical practice MD Revolution.
Read MoreJay M. Lieberman, MD, an expert in infectious diseases and emerging infectious diseases, is medical director of infectious diseases for Quest Diagnostics, Madison, NJ, and medical and laboratory director for Focus Diagnostics. CLP spoke with him about the West Nile virus outbreak.
Read More